A microarray is a laboratory tool majorly used to detect the expressions of a large number of genes at the same time. DNA micro-arrays are small slides used under the microscope. These slides are printed with many tiny spots in defined positions. Each spot contains a known gene or DNA sequence. Micro-array equipment is used in sequencing applications and genome mapping. However, recently the use of the equipment has broadened to domains such as cancer diagnostics, pharmacogenomic research, drug discovery, genetic disease diagnostics, and forensics. In addition, micro-array equipment is used in immunology research for analysis of allergies, activation of immune cells, and immunological pharmacology.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness significant growth in the future, owing to the demand for vaccines and treatment drugs for COVID-19.
With COVID-19 the supply chain of raw materials required to manufacture micro-array equipment has been disrupted in many countries. In addition, the market growth of micro-array equipment is declining as the manufacturers of these devices have slowed down their production due to the pandemic. Therefore, COVID 19 is expected to have a significant impact on the micro-array equipment market.
Top Impacting Factors
Micro-array equipment is used by various pharmaceutical companies in drug discovery, as it helps measure expression patterns of different genes, generating data in the identification of appropriate target patients for clinical trials of drugs. The rise in the number of activities of drug discovery such as patient trials has increased the use of micro-array equipment, thus positively influencing the market.
DNA micro-array equipment is used in diagnosing various types of cancers. Thus, alarming rise in the prevalence of cancer cases all over the world has boosted the growth of the micro-array equipment market.
The use of micro-array analysis is effective in antibiotic treatment, as only a small amount of bacterial DNA can be used to diagnose the type of bacterial infection that the patient might be suffering from. This factor has further led to the growth of the micro-array equipment market.
However, lack of skilled personnel who can handle micro-array equipment and high cost associated with micro-array analysis are some of the factors that can act as a restraint for the micro-array equipment market.
Key Market Trends
Rising number of product launches is expected to propel the growth of the micro-array equipment market. For instance, in 2015, PerperPRINT Inc. launched its PEPperCHIP Allergen Epitope Microarray, which enables high throughput screening of Immunoglobulin E antibody response from serum and plasma. This product enables easy profiling of blood sera immune responses related to infectious diseases, autoimmune diseases, and cancer.
Leading market players have developed a wide range of instruments and services. For instance, Thermo Fisher Scientific Inc. launched its GeneChip Scanner, which helps scan next-generation high-density micro-array for all-axon arrays.
Thermo Fisher Scientific Inc. further offers its Gene Chip Hybridization Oven, which allows precise rotation and temperature of samples enabling successful hybridization.
North America holds a large share of the micro-array equipment market, owing to the presence of major market players and increased adoption rate of micro-array equipment for diagnostic purposes in hospitals and laboratories.
Key Benefits of the Report
- This study presents the analytical depiction of the micro-array equipment industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the market share.
- The current market is quantitatively analyzed to highlight the growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.
Questions Answered in the Micro-array Equipment Report
- Which are the leading players active in the micro-array equipment market?
- How is each segment of the market expected to grow during the forecast period?
- What are the adoption trends for the micro-array equipment market in emerging economies and established economies across the world?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps in the market?
- What are the impacts of COVID-19 on the industry?
- What is micro-array equipment?
- What are the current and predicted trends of the market?
Micro-array Equipment Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Type |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Arrayit Corporation, Merck KGaA, Illumina, Inc., Molecular Devices, LLC, Bio-Rad Laboratories, Agilent Technologies, Inc., GE Healthcare, PerkinElmer Inc., Microarrays, Inc., Thermo Fisher Scientific Inc. |
Loading Table Of Content...
